Predict your next investment

Adrenomed company logo
HEALTHCARE | Biotechnology
adrenomed.com

See what CB Insights has to offer

Founded Year

2009

Stage

Series E | Alive

Total Raised

$53.9M

Last Raised

$26.68M | 10 mos ago

About Adrenomed

Adrenomed is a Gernan biopharmaceutical company focused on discovering and developing monoclonal antibody therapies that target the vasoactive adrenomedullin system in order to treat sepsis, septic shock and acute kidney injury.

Adrenomed Headquarter Location

Neuendorfstraße 15A

Hennigsdorf, 16761,

Germany

+49 (0) 3302 20 77 8 0

Latest Adrenomed News

Adrenomed: Participation in Upcoming Scientific and Industry Events

Aug 30, 2021

DGAP-News: Adrenomed AG / Key word(s): Conference 30.08.2021 / 16:57 The issuer is solely responsible for the content of this announcement. Adrenomed Announces Participation in Scientific and Industry Events in September and October 2021 Hennigsdorf/Berlin (Germany), August 30th, 2021 - Adrenomed AG, the vascular integrity company, announced today its participation in four upcoming scientific and industry events. Adrenomed representatives will be...

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Adrenomed

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Adrenomed is included in 3 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

13,989 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

I

Infectious Disease

2,222 items

Entities aiding the surveillance, screening, prevention, diagnosis, treatment, and containment of infections & the maintenance of public wellbeing during outbreaks.

Adrenomed Patents

Adrenomed has filed 12 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Intensive care medicine
  • Syndromes
patents chart

Application Date

Grant Date

Title

Related Topics

Status

9/20/2018

10/13/2020

Intensive care medicine, Clusters of differentiation, G protein coupled receptors, Syndromes, Proteins

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

9/20/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/13/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Intensive care medicine, Clusters of differentiation, G protein coupled receptors, Syndromes, Proteins

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Adrenomed Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Adrenomed Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.